Drug Type Polymer |
Synonyms |
Target |
Action agonists |
Mechanism Heparin agonists |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (European Union) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Phase 2 | - | - | |
Sepsis | Phase 2 | - | - | |
Anemia, Sickle Cell | Preclinical | Bahrain | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Lebanon | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Oman | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Jamaica | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Saudi Arabia | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Turkey | 01 Jul 2015 | |
Anemia, Sickle Cell | Preclinical | Netherlands | 01 Jul 2015 | |
Vaso-occlusive crisis | Preclinical | Lebanon | 01 Jul 2015 |
Phase 2 | 144 | twltvddngb(tqqaghkqds) = rjpffiflda ewopubrlfi (qfpxhrgxsy, 85.5 - 116.8) View more | Negative | 01 May 2021 | |||
Placebo | twltvddngb(tqqaghkqds) = mlwtkdlmzv ewopubrlfi (qfpxhrgxsy, 70.6 - 95.1) View more |